News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
SBP GROUP: Culmerciclib Capsules Approved in CN for 2nd Indication
SBP GROUP (01177.HK) announced that culmerciclib capsule “CDK2/4/6 inhibitor”, in combination with fulvestrant, has received approval for marketing from the National Me...
Reset
Send
The window will close in 5 seconds
SBP GROUP: Culmerciclib Capsules Approved in CN for 2nd Indication
Close
Recommend
13
Positive
19
Negative
4
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get Level 1 Real-Time Streaming!

SBP GROUP (01177.HK)  -0.060 (-1.062%)    Short selling $71.83M; Ratio 16.178%   announced that culmerciclib capsule “CDK2/4/6 inhibitor”, in combination with fulvestrant, has received approval for marketing from the National Medical Products Administration (NMPA) of China for the initial endocrine therapy for patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer.

Culmerciclib capsule “CDK2/4/6 inhibitor” is a national Category 1 innovative drug independently developed by the Group’s subsidiary, Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CTTQ). This is the second indication approved for marketing of culmerciclib.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-14 16:25.)

Related NewsG Sachs Raises SBP GROUP (01177.HK) TP to HKD8.05, Maintains Buy on Introduction of GSK Hepatitis B Drug

Auto-translated by AI
View Original Text
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.